AbCellera Biologics (ABCL)
(Delayed Data from NSDQ)
$2.48 USD
-0.09 (-3.50%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $2.48 0.00 (0.00%) 6:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
AbCellera Biologics Inc. (ABCL) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$13.38 | $28.00 | $5.00 | 420.62% |
Price Target
Based on short-term price targets offered by eight analysts, the average price target for AbCellera Biologics Inc. comes to $13.38. The forecasts range from a low of $5.00 to a high of $28.00. The average price target represents an increase of 420.62% from the last closing price of $2.57.
Analyst Price Targets (8 )
Broker Rating
AbCellera Biologics Inc. currently has an average brokerage recommendation (ABR) of 1.22 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by nine brokerage firms. The current ABR compares to an ABR of 1.22 a month ago based on nine recommendations.
Of the nine recommendations deriving the current ABR, eight are Strong Buy, representing 88.89% of all recommendations. A month ago, Strong Buy represented 88.89%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 8 | 8 | 8 | 9 | 9 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.22 | 1.22 | 1.22 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/23/2024 | Cowen & Co. | Brendan Smith | Not Available | Strong Buy |
8/20/2024 | The Benchmark Company | Robert Wasserman | Strong Buy | Hold |
8/8/2024 | Bloom Burton & Company | David Martin | Strong Buy | Strong Buy |
8/7/2024 | Piper Sandler | Allison M Bratzel | Strong Buy | Strong Buy |
8/6/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
5/8/2024 | KeyBanc Capital Markets | Scott Schoenhaus | Strong Buy | Strong Buy |
4/12/2024 | SVB Securities | Puneet Souda | Strong Buy | Strong Buy |
4/1/2024 | BMO Capital Markets | Evan Seigerman | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.22 |
ABR (Last week) | 1.22 |
# of Recs in ABR | 9 |
Average Target Price | $13.38 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 77 of 252 |
Current Quarter EPS Est: | -0.14 |
ABCL FAQs
AbCellera Biologics Inc. (ABCL) currently has an average brokerage recommendation (ABR) of 1.22 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 9 brokerage firms.
The average price target for AbCellera Biologics Inc. (ABCL) is $13.38. The current on short-term price targets is based on 5 reports.
The forecasts for AbCellera Biologics Inc. (ABCL) range from a low of $5 to a high of $28. The average price target represents a increase of $420.62 from the last closing price of $2.57.
The current UPSIDE for AbCellera Biologics Inc. (ABCL) is 420.62%
Based on short-term price targets offered by eight analysts, the average price target for AbCellera Biologics Inc. comes to $13.38. The forecasts range from a low of $5.00 to a high of $28.00. The average price target represents an increase of 420.62% from the last closing price of $2.57.